期刊文献+

平阳霉素加地塞米松瘤内注射治疗口腔颌面部脉管畸形的临床研究 被引量:2

Study of local injection of pingyangmycin plus dexamethason in treat ment of vascular malformation of oral and maxillofacial region
下载PDF
导出
摘要 目的:研究平阳霉素加地塞米松瘤内注射治疗口腔颌面部脉管畸形的效果。方法:将平阳霉素8mg+地塞米松注射液1ml+2%利多卡因注射液(1-2)ml+生理盐水(2-4)ml稀释成平阳霉素的浓度为(1-2)mg/ml,行瘤内注射至表面肿胀发白,每次平阳霉素用量不超过8mg,14天-21天复诊,未愈者重复注射。结果:随访6个月-2年,治愈210例,占76.09%,显效65例,占23.55%,无效:1例,占0.36%。总有效率99.64%。结论:平阳霉素加地塞米松局部注射治疗口腔颌面部脉管畸形,具有疗效显著、简便易行、安全可靠等优点,是脉管畸形治疗的首选方法。 Objective: To study the treatment effect on vascular malformation of oral and maxillofacial region with pingyangmycin plus dexamethason by local injection. Methods: 8mg of pingyangmycin was dissolved in 2 -4 of normal saline ,5mg( 1 ml) of dexamethason and 1 - 2ml of 2% lidocaine, concentration of pingyangmycin was 1 - 2mg/ ml. Pingyangmycin solution was injected into hemangioma until it began to swell and got pale with a dose less than 8mg. If patient was not cured after 14 -21 days, inject again. Re.suits:After 6 months to 2 years,the cure rate was 76.09% ,the effective rate was 23.55% ,the ineffective rate was 0.36%. The total effective rate was 99.64%. Conclusion: The treatment effect is reliable, prominent and safe. It is easily operated, and recommendable therapy for vascular malformation of oral and maxillofaeial region.
出处 《现代肿瘤医学》 CAS 2008年第9期1476-1478,共3页 Journal of Modern Oncology
关键词 平阳霉素 地塞米松 口腔颌面部 脉管畸形 注射治疗 pingyangmycin dexamethason oral and maxillofacial region vascular malformation local injection
  • 相关文献

参考文献6

二级参考文献20

  • 1寿柏泉,杨震,孟昭业,郑葆春.平阳霉素治疗草莓状和混合性血管瘤的临床研究──附118例报告[J].实用口腔医学杂志,1995,11(1):16-18. 被引量:29
  • 2徐泉,李恭才.血管瘤的研究现状[J].中级医刊,1996,31(3):12-14. 被引量:7
  • 3佘亚雄 佘亚雄 应大明.血管瘤[A].佘亚雄,应大明.小儿肿瘤学:第1版[C].上海:上海科学技术出版社,1997.191~201.
  • 4赵佩云 吴瑞萍 胡亚美 江载芳.皮肤与躯体软组织肿瘤[A].吴瑞萍,胡亚美,江载芳.诸福棠实用儿科学:第6版[C].北京:人民卫生出版社,1996.2196~2203.
  • 5Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plastic Resconser Surg, 1982,69: 412-420.
  • 6谭中楷.皮肤血管瘤治疗的进展[J].国外医学皮肤病学分册,1983,4:193-193.
  • 7Folkman J. Clincal applications of research onangiogenesis[J].N Engl Med,1995,333(26):1757.
  • 8Liekens S, Verbeken E, Vandeputte M, et al.A novel animal model for inhivitor TNP-470[J].Cancerres,1999,59(5):2376.
  • 9Silverman R A. He mangiomas and vascular malformations[J].Pediatr Clin NorthAm,1991,38(4):811.
  • 10Hurvitz C H, Alkalag L A, Sloninsky L, et al. Clinical and laboratory observations cyclophaspphamide therapy in lifethreatening vascular tumors[J].J pediatrics,1986,109:360.

共引文献79

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部